The Research Institute of Molecular Pathology (IMP) is a basic research institute in Vienna, Austria. Its main sponsor is Boehringer Ingelheim International, headquartered in Germany. With over 200 employees from 28 different nations, the IMP is a Center of Excellence in the life sciences and the core unit of the Campus Vienna Biocenter. Research at the IMP aims at elucidating the molecular basis of normal development and disease.